(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEUROVIVE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEUROVIVE

ST13

US500000079047227

Class

5

Filing

79047227

Registration

3520893

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

02/21/2026

Trademark type

Word

Nice classes

5

Filing date

09/07/2007

Registration date

10/21/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2019

Last transaction

02/21/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

NL

Examiner

MAKHDOOM, SAIMA

Law office

L10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Pharming Intellectual Property B.V.
Abliva AB
NeuroPharma I Sverige AB

Representatives

Paul F. Kilmer Holland & Knight LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary preparationsmedicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; Medicines and pharmaceutical preparations for the treatment of neurosurgical conditionsfor brain damage and for use in brain operations and other physical and neurological ailments of the brain; Medicines and pharmaceutical preparations for use in the area of neurological intensive care; Medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents and preparations

Publications

History of USPTO decisions and trademark events.

42 publications found

CHLD

CHANGE OF OWNER RECEIVED FROM IB

02/19/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/08/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/01/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/27/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/23/2020

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

03/20/2020

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/21/2020

INPC

INVALIDATION PROCESSED

02/21/2020

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

01/24/2020

C71T

CANCELLED SECTION 71

05/24/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/12/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/12/2018

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

10/21/2017

RNWL

INTERNATIONAL REGISTRATION RENEWED

09/28/2017

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

05/07/2015

71AG

REGISTERED-SEC.71 ACCEPTED

05/07/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/07/2015

ES71

TEAS SECTION 71 RECEIVED

04/21/2015

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/28/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/07/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/04/2009

FIMP

FINAL DISPOSITION PROCESSED

02/04/2009

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/22/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

10/21/2008

PUBO

PUBLISHED FOR OPPOSITION

08/05/2008

NPUB

NOTICE OF PUBLICATION

07/16/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/30/2008

ALIE

ASSIGNED TO LIE

06/30/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/29/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/13/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/13/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/13/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/13/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/13/2008

RFNT

REFUSAL PROCESSED BY IB

02/01/2008

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/10/2008

RFRR

REFUSAL PROCESSED BY MPU

01/10/2008

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/10/2008

CNRT

NON-FINAL ACTION WRITTEN

01/09/2008

DOCK

ASSIGNED TO EXAMINER

12/31/2007

NWAP

NEW APPLICATION ENTERED

12/31/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/28/2007

Continuous trademark protection

Get notified about every new filing that threatens NEUROVIVE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.